Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5

Author： Gravesen Eva Hofman-Bang Jacob Lewin Ewa Olgaard Klaus

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.73, Iss.2, 2013-03, pp. : 107-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

S100A12 Gene Expression Is Increased in Peripheral Leukocytes in Chronic Kidney Disease Stage 4-5 Patients with Cardiovascular Disease

Nephron Clin Pract, Vol. 123, Iss. 3-4, 2013-08 ,pp. : 202-208

Karger

Access to resources Recommend Favorite

Multidisciplinary Care Improves Outcome of Patients with Stage 5 Chronic Kidney Disease

Nephron Clin Pract, Vol. 115, Iss. 4, 2010-04 ,pp. : c283-c288

Karger

Access to resources Recommend Favorite

Treatment and costs associated with anemic chronic kidney disease patients

By Rasu Rafia S. Crawford Tonya Manley Harold Balkrishnan Rajesh

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 129-137

Informa Healthcare

Access to resources Recommend Favorite

Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease

Nephron Clin Pract, Vol. 120, Iss. 3, 2012-06 ,pp. : c147-c155

Karger

Access to resources Recommend Favorite

Chronic Kidney Disease-Related Mineral and Bone Disorders

Nephron Clin Pract, Vol. 112, Iss. 3, 2009-04 ,pp. : c128-c136

Karger

Access to resources Recommend Favorite